| Trial ID: | L4673 |
| Source ID: | NCT00948402
|
| Associated Drug: |
Metformin
|
| Title: |
PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Polycystic Ovarian Syndrome|Insulin Sensitivity
|
| Interventions: |
DRUG: Metformin|DRUG: oral contraceptive
|
| Outcome Measures: |
Primary: PED/PEA-15 protein expression, 6 months | Secondary: BMI, plasma glucose, plasma insulin, insulin sensitivity indexes (1/HOMA-IR, homeostasis model assessment of insulin resistance; QUICKI, quantitative insulin sensitivity check index; ISI, whole-body insulin sensitivity index)., 6 months
|
| Sponsor/Collaborators: |
Sponsor: Federico II University
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-12
|
| Completion Date: |
2009-01
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-14
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00948402
|
